Xie F - Search Results

1

The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.

Xie F, Huang M, Lin X, Liu C, Liu Z, Meng F, Wang C, Huang Q. Xie F, et al. Sci Rep. 2018 May 25;8(1):8102. doi: 10.1038/s41598-018-26496-0. Sci Rep. 2018. Retraction in: Sci Rep. 2023 Nov 28;13(1):20934. doi: 10.1038/s41598-023-48298-9 PMID: 29802402 Free PMC article. Retracted.

2

Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein.

Lin X, Huang M, Xie F, Zhou H, Yang J, Huang Q. Lin X, et al. Among authors: xie f. Oncotarget. 2016 Oct 25;7(43):70092-70099. doi: 10.18632/oncotarget.11780. Oncotarget. 2016. PMID: 27602753 Free PMC article.

3

Fragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway.

Huang Q, Liu Z, Xie F, Liu C, Shao F, Zhu CL, Hu S. Huang Q, et al. Among authors: xie f. ScientificWorldJournal. 2014 Mar 16;2014:179698. doi: 10.1155/2014/179698. eCollection 2014. ScientificWorldJournal. 2014. PMID: 24757411 Free PMC article.

4

MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.

Liu Z, Jin ZY, Liu CH, Xie F, Lin XS, Huang Q. Liu Z, et al. Among authors: xie f. Int J Clin Exp Pathol. 2015 May 1;8(5):4684-94. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191158 Free PMC article.

5

MSI2 knockdown represses extrahepatic cholangiocarcinoma growth and invasion by inhibiting epithelial-mesenchymal transition.

Hu F, Liu C, Xie F, Lin X, Yang J, Wang C, Huang Q. Hu F, et al. Among authors: xie f. Onco Targets Ther. 2018 Jul 13;11:4035-4046. doi: 10.2147/OTT.S170739. eCollection 2018. Onco Targets Ther. 2018. PMID: 30034243 Free PMC article.

6

Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC).

Xie F, Huang Q, Wang C, Chen S, Liu C, Lin X, Lv X, Wang C. Xie F, et al. Cancer Biomark. 2020;27(3):357-364. doi: 10.3233/CBM-190908. Cancer Biomark. 2020. PMID: 31929143

7

Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.

Zhu CL, Huang Q, Liu CH, Xie F. Zhu CL, et al. Among authors: xie f. Mol Biol Rep. 2012 Sep;39(9):8701-8. doi: 10.1007/s11033-012-1727-4. Epub 2012 Jun 19. Mol Biol Rep. 2012. PMID: 22711308

8

[Molecular mechanism of γ-aminobutyric acid inhibitory on the growth of cholangiocarcinoma QBC939 cell line].

Zhu CL, Huang Q, Liu CH, Xie F, Zhu K. Zhu CL, et al. Among authors: xie f. Zhonghua Wai Ke Za Zhi. 2013 Mar;51(3):261-5. Zhonghua Wai Ke Za Zhi. 2013. PMID: 23859331 Chinese.

9

Prognostic value of HIF-1α expression in patients with gastric cancer.

Zhu CL, Huang Q, Liu CH, Lin XS, Xie F. Zhu CL, et al. Among authors: xie f. Mol Biol Rep. 2013 Nov;40(11):6055-62. doi: 10.1007/s11033-013-2715-z. Epub 2013 Sep 23. Mol Biol Rep. 2013. PMID: 24057269 Review.

10

Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.

Liu CH, Huang Q, Jin ZY, Xie F, Zhu CL, Liu Z, Wang C. Liu CH, et al. Among authors: xie f. J Cancer Res Ther. 2018 Jan;14(1):220-225. doi: 10.4103/0973-1482.193125. J Cancer Res Ther. 2018. PMID: 29516989 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,575 results

Search Page

Filters